$250 | Single User
$500 | Site License
$750 | Enterprise License

One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Lowest Price Guaranteed: $250]

Published by Global Data: 10 May 2016 | 12078 | In Stock
Related Topics: Business , Equity , Financial , Healthcare , Pharmaceuticals

Introduction

Summary

ONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagnosis. It offers services such as screening services, biomarker search and identification, companion diagnostics and drug development optimization. OWL also offers metabolomic services to pharmaceutical and biotechnology companies in the areas including clinical studies, biomarker discovery, companion diagnostics and toxicology. The company serves pharmaceutical, food and cosmetics industries, research centers, biotech companies and CROs. OWL is headquartered in Derio, Spain.

One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

    One Way Liver, S.L., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

    One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

    One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

    One Way Liver, S.L., Medical Devices Deals, 2010 to YTD 2016 9

    One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

    One Way Liver, S.L., Pharmaceuticals & Healthcare, Deal Details 11

    Venture Financing 11

    OWL Genomics Secures US.7 Million In Venture Financing 11

    Partnerships 12

    Immuron Enters into Agreement with One Way Liver Genomics 12

    Equity Offering 13

    One Way Liver Genomics to Raise USD0.2 Million in Financing Round 13

    Acquisition 14

    OWL Genomics Acquires MDRenal Life Sciences 14

    One Way Liver, S.L. - Key Competitors 15

    Key Employees 16

    Locations And Subsidiaries 17

    Head Office 17

    Appendix 18

    Methodology 18

    About GlobalData 18

    Contact Us 18

    Disclaimer 18

List Of Tables
in One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

One Way Liver, S.L., Pharmaceuticals & Healthcare, Key Facts 1

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

One Way Liver, S.L., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

One Way Liver, S.L., Deals By Therapy Area, 2010 to YTD 2016 8

One Way Liver, S.L., Medical Devices Deals, 2010 to YTD 2016 9

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10

OWL Genomics Secures US.7 Million In Venture Financing 11

Immuron Enters into Agreement with One Way Liver Genomics 12

One Way Liver Genomics to Raise USD0.2 Million in Financing Round 13

OWL Genomics Acquires MDRenal Life Sciences 14

One Way Liver, S.L., Key Competitors 15

One Way Liver, S.L., Key Employees 16

List Of Figures, Charts and Diagrams
in One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

One Way Liver, S.L., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

One Way Liver, S.L., Medical Devices Deals, 2010 to YTD 2016 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

12078 | GDPH251555D

Number of Pages

18

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Liver Cancer Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Liver Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical...
14 Sep 2016 by Global Data USD $4,000 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
22 Aug 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
15 Apr 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
15 Mar 2016 by Global Data USD $250 More Info
One Way Liver, S.L. - Medical Equipment - Deals and Alliances Profile
SummaryONE WAY LIVER, S.L (OWL), formerly One Way Liver Genomics, S.L., is a biotechnology company t...
25 Feb 2016 by Global Data USD $250 More Info
Rising Stars Outlook 2016 :New Emergence of Potential Tx & Dx Options could transform the Current Landscape for Liver Diseases (NASH)
Non-Alcoholic SteatoHepatitis (NASH) is an unmet medical need and is becoming the leading cause of l...
01 Feb 2016 by MP Advisors USD $2,000 More Info
Liver Diseases Global Clinical Trials Review, H2, 2015
Liver Diseases Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Li...
16 Dec 2015 by Global Data USD $2,500 More Info
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015SummaryGlobalData's...
16 Dec 2015 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

One Way Liver, S.L. - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...